Results 201 to 210 of about 150,385 (309)

Repurposing the antispasmodic drug pinaverium bromide as a novel antifungal agent and synergist against <i>Candida albicans</i>. [PDF]

Virulence
Yao J, Yang Z, Hang X, Chen T, Li B, Shi T, Quan K, Xu J, Zeng L, Feng G, Bi H.   +10 more
europepmc   +1 more source

Candida albicans [PDF]

, 2020
openaire   +1 more source

Antimicrobial activity of a decapeptide against <i>Candida albicans</i>. [PDF]

Microbiol Spectr
Li Z, Liu Y, Yuan Y, Sun Z, Zhang J, Dai Q, Li S, Deng B, Zhang W, Dong Y, Liang G, Gao S.   +11 more
europepmc   +1 more source

The oral microbiota and periodontal health in orthodontic patients

Periodontology 2000, EarlyView.
Abstract The oral microbiota develops within the first 2 years of childhood and becomes distinct from the parents by 4 years‐of‐age. The oral microbiota plays an important role in the overall health/symbiosis of the individual. Deviations from the state of symbiosis leads to dysbiosis and an increased risk of pathogenicity.
Brandon W. Peterson, Geerten‐Has Tjakkes, Anne‐Marie Renkema, David J. Manton, Yijin Ren   +4 more
wiley   +1 more source

Engineered surface strategies to manage dental implant‐related infections

Periodontology 2000, EarlyView.
Abstract When exposed to the oral environment, dental implants, like natural surfaces, become substrates for microbial adhesion and accumulation, often leading to implant‐related infections—one of the main causes of implant failure. These failures impose significant costs on patients, clinicians, and healthcare systems.
João Gabriel S. Souza, Bruna E. Nagay, Rodrigo Martins, Martinna Bertolini, Jamil A. Shibli, Conrado Aparicio, Magda Feres, Valentim A. R. Barão   +7 more
wiley   +1 more source

Isobavachalcone effectively inhibits the growth of <i>Candida albicans</i>. [PDF]

Antimicrob Agents Chemother
Xie P, Zhou W, Luo J, Dai Y, Yang S, Li S, Huang Y.   +6 more
europepmc   +1 more source

Emerging locally delivered antimicrobial and immunomodulatory approaches for the prevention/treatment of peri‐implant diseases

Periodontology 2000, EarlyView.
Abstract Peri‐implant diseases are dysbiosis‐mediated inflammatory disorders that occur in susceptible hosts. Antimicrobials and immunomodulatory agents therefore might be pertinent as adjunctive measures in the treatment of such disorders. The aim of this narrative review was to examine the existing evidence and assess the effectiveness of emerging ...
Alberto Monje, Ettore Amerio, Irene Mallor, Conrado Aparicio   +3 more
wiley   +1 more source

Antifungal susceptibility, FKS1 gene expression, and virulence determinants of Candida albicans in pediatric and neonatal candidiasis. [PDF]

BMC Infect Dis
Rezaei-Mojaz M, Hajghafari H, Shams-Ghahfarokhi M, Seyedjavadi S, Salehi Z, Eslamifar A, Jamzivar F, Razzaghi-Abyaneh M.   +7 more
europepmc   +1 more source

Antibiotic‐mediated immune modulation in periodontitis

Periodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez, R. M. Arce, Camila Pinheiro Furquim, Cristiane Gonçalves, Alpdogan Kantarci, Magda Feres, Nidia C. Castro dos Santos   +6 more
wiley   +1 more source

The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole. [PDF]

BMC Microbiol
Pan J, Yao Z, Zhang J, Hu P, Ye L, Zhou B, Shi S, Sun Y, Zhou T.   +8 more
europepmc   +1 more source